Thank you to our sponsors
Platinum Sponsor
At AstraZeneca Australia and New Zealand, we have been working to deliver life-changing medicines to patients for more than 60 years.
AstraZeneca is a global, science-led biopharmaceutical company engaged in the research, development, manufacture and supply of medicines that aim to make a real difference to the lives of Australians and New Zealanders. Our areas of focus include four therapy areas – Oncology; Cardiovascular, Renal and Metabolism (CVRM); and Respiratory and Immunology (R&I).
We build our own capabilities by collaborating with world-renowned scientists, academic institutions, and like-minded, science-led companies.
Silver Sponsor
Servier is an independent pharmaceutical company governed by a foundation. Free from shareholders, Servier is fully committed to discovering and delivering therapeutic progress to meet patient needs.
Servier recognises the important efforts of the National Hypertension Taskforce and other key organisations to improve Australia’s BP control rate from 32% to 70% by 2030. As a key industry partner, we have provided support such as HCP and patient education, as well as projects and initiatives aimed at improving awareness, diagnosis, and treatment of hypertension.
Meeting Supporter
Every day, millions of patients, caregivers, and healthcare providers rely on Baxter’s leading portfolio of diagnostic, critical care, nutrition, hospital, and surgical products used across patient homes, every hospital department, physician offices and other sites of care. For over 90 years, Baxter has been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers who make it happen.
Baxter’s products, digital health solutions and therapies are available in more than 100 countries where Baxter employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.
With the acquisition of Welch Allyn, Baxter now proudly supplies the Connex range of patient monitors, offering BP averaging technology for improved detection of hypertension, and enhancing patient care through advanced monitoring technology, ensuring timely and accurate vital signs measurements.
Tabletop Exhibitors
Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 66,700 people in 80 countries and markets its products in around 170 countries.
Novo Nordisk has been operating in Australia since 1976. We deliver medicines to more than 1.6 million patients in Australia for the treatment of diabetes, obesity, rare diseases and other serious chronic diseases. For more information, visit www.novonordisk.com.au
Diasorin is committed to improving healthcare by providing an unparalleled portfolio of exclusive, high-quality immunoassays and fully automated chemiluminescence analyzers that deliver standardised and unbiased results. As easy-to-use as they are reliable, we allow laboratory and healthcare professionals to streamline their diagnostic pathways while ensuring complete harmonisation between urgent, specialty and routine tests.